ScrutarSign up free

VEEVA SYSTEMS INC (VEEV)

SEC filings, insider trading & institutional ownership from EDGAR.

Veeva Systems Inc. is a provider of industry cloud solutions for the global life sciences industry, spanning cloud software, data, and business consulting. Its offerings are designed to help life sciences companies develop and bring products to market faster, market and sell more effectively, and maintain compliance with government regulations, from research and development through commercialization. Veeva is a Delaware public benefit corporation, with a stated purpose of providing products and services that help make the industries it serves more productive and creating high-quality employment opportunities in the communities where it operates.

The solutions are grouped into four product categories. Veeva Development Cloud covers clinical, regulatory, and safety functions, including clinical data management and operations (EDC, CDB, eTMF, CTMS, RTSM), Veeva Safety, and Veeva RIM, all built on the Veeva Vault platform. Veeva Quality Cloud includes Veeva QMS, Quality Docs, lab, and training solutions. Veeva Commercial Cloud includes Vault CRM and the legacy Veeva CRM, Veeva Medical, PromoMats, and Crossix marketing analytics. Veeva Data Cloud includes OpenData, Veeva Link, Compass, and HCP Access. Veeva AI adds agentic AI agents to Vault and its applications. For financial reporting, Commercial Solutions combines Commercial Cloud and Data Cloud, while R&D and Quality Solutions combines Development Cloud and Quality Cloud. Veeva also provides professional services (implementation, managed services, data migration, training) and Veeva Consulting for commercial and R&D strategy.

As of January 31, 2026, Veeva served 1,552 customers, including pharmaceutical, biotechnology, and medical device companies, contract sales organizations, and contract research organizations. These range from large global companies such as Bayer, Eli Lilly, Gilead, Merck, and Novartis to emerging biotechs such as Alkermes and Alnylam. Some Development and Quality Cloud applications are also sold to consumer products companies and others outside life sciences. Veeva sells through a direct sales organization with separate R&D and quality and commercial teams, further divided between large global and smaller life sciences companies.

Veeva had 7,928 employees as of January 31, 2026. Its products are hosted in third-party data centers in the United States, European Union, Japan, South Korea, Singapore, Australia, Brazil, and China. Vault applications run on Amazon Web Services, while Veeva CRM runs on Salesforce infrastructure, and its AI Agents use large language models from Anthropic and Amazon. Its technology is generally multitenant, and it maintains an ISO 9001 quality management system and a data privacy program. Competitors include Salesforce in CRM, IQVIA, Ipsos, and Definitive Health in data, and IQVIA, Dassault Systèmes, OpenText, Oracle, and Honeywell in development and quality applications. Veeva relies on patents, trade secrets, copyrights, and trademarks, with 111 issued U.S. patents and 164 pending applications.

AI-summarized from Item 1 (Business) of the company’s most recent 10-K filing.

RevenueFY2026
$3.2B
▲ 16.3%YoY
Net incomeFY2026
$908.91M
▲ 27.3%YoY
Diluted EPSFY2026
$5.44
▲ 25.9%YoY
Gross margin
75.5%
▲ 100 bpsYoY
Insider net6 mo
−471.5K
shares7 sells0 buys
Institutions
59
$14.83B held

Financials

As reported to the SEC via XBRL, no adjustments

All financials →
Revenue & net income
$1B$2B$3B$4B
FY2023FY2024FY2025FY2026
RevenueNet income
FY2026 highlightsfrom 10-K
Gross profit$2.41B
Operating income$916.37M
Diluted EPS$5.44
Gross margin75.5%
Net margin28.4%

Latest filings

10-K, 10-Q, 8-K, Form 4 & 13D/G. Sourced directly from SEC EDGAR

All filings →
FormFiledAccession
8-KNov 6, 2026EDGAR
4Ritter GordonOct 19, 2026EDGAR
4Faddis JonathanOct 17, 2026EDGAR
4Zuppas Eleni NitsaOct 6, 2026EDGAR
4Van Wagener BrianOct 6, 2026EDGAR
4Schwenger Thomas D.Oct 6, 2026EDGAR
4Rizzo Daniel JOct 6, 2026EDGAR
4Kondath VipinOct 6, 2026EDGAR

Insider trading

From Form 4 filings

All →
InsiderDateType
Ritter GordonOct 15, 2026J
Ritter GordonOct 15, 2026Acquire (J)
Faddis JonathanOct 14, 2026Sell
Faddis JonathanOct 2, 2026Gift
Rizzo Daniel JOct 2, 2026Sell

Top holders

13F & 13D/G • latest quarter

All →
HolderStakeFiledValue
BlackRock, Inc.7.9%Aug 7, 2026$2.28B
Vanguard Capital Management6.0%Aug 13, 2026$1.72B
Vanguard Portfolio Management4.6%Aug 13, 2026$1.32B
GEODE CAPITAL MANAGEMENT, LLC2.8%Nov 6, 2026$1.3B
STATE STREET CORPORATION4.1%Sep 22, 2026$1.19B

VEEV's filings are public. The insight is one click away.

Scrutar's AI reads every VEEV filing and points out what matters. Red flags, risk shifts, disclosure quality and key relationships. Cited to the source, free with an account.

Analyze VEEV filingsNo credit cardAI reports included on the free plan

Never miss a VEEV filing.

Get an email when VEEV files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.

Free foreverNo account requiredOne-click unsubscribe

Protected by reCAPTCHA. Privacy & Terms

Data as of Nov 8, 2026Source: SEC EDGAR.